If you experience persistent muscle weakness, fatigue and skin changes that don't seem to fade, it could be more than just ...
Received FDA orphan drug designation for the treatment of dermatomyositis in April 2017. Received FDA approval for the treatment of dermatomyositis in adults in July 2021. In ITP, Octagam 10% ...
Several known risk factors of Dermatomyositis (DM ... She is recognized for her contributions to advancing treatment options and understanding of these challenging conditions.
Lundberg agrees: “It would be very interesting to test treatment with IL-6 antibodies in patients with polymyositis, and probably also dermatomyositis.” ...